Please provide your email address to receive an email when new articles are posted on . The FDA granted marketing approval to allow the Eversense E3 CGM to be integrated with insulin delivery systems.
Please provide your email address to receive an email when new articles are posted on . A new policy implemented by Stanford Health Care allowed people to use their own CGMs in the hospital. Most ...
MADRID — The use of continuous glucose monitoring (CGM) reduced the risk for hospitalization and improved glucose control in people with type 2 diabetes, regardless of insulin use, a new analysis of ...
Diabetes devices using CGM technology can be costly, even for those with insurance. Consider these tips and ask your doctor, insurer, or device manufacturer about any access or affordability programs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results